EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) reported 1 transaction at AIM IMMUNOTECH INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/16/2026ACC: 0001493152-26-010334
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+24.98K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
25K acquired · 25.00 disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
64.2%
3/12/2026
38.92K→63.92K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 3/12/2026 | C · Conversion | +25K | — | — | 64.2% | 38.92K | 63.92K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Series G Convertible Preferred Stock
Direct
Converts to
common stock
25K shares
Shares
−25.00
Strike price
Held after
0.00
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series G Convertible Preferred Stock Direct | common stock25K shares | 3/12/2026 | C · Conversion | −25.00 | — | 0.00 |